University Hospitals Bristol and Weston NHS Foundation Trust
- Country
- 🇬🇧United Kingdom
- Ownership
- -
- Established
- 1990-01-01
- Employees
- -
- Market Cap
- -
- Website
- https://www.uhbw.nhs.uk/
Clinical Trials
23
Trial Phases
5 Phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (20 trials with phase data)• Click on a phase to view related trials
Acceptance and Commitment Therapy in Tuberous Sclerosis Complex
- Conditions
- Tuberous Sclerosis Complex
- First Posted Date
- 2023-05-22
- Last Posted Date
- 2024-02-14
- Target Recruit Count
- 15
- Registration Number
- NCT05867576
- Locations
- 🇬🇧
University Hospitals Bristol and Weston NHS Trust, Bristol, United Kingdom
Comparison of Huntleigh Dopplex DMX Digital Doppler Arterial Waveform With the Gold Standard of Ultrasound Duplex Arterial Waveform
- Conditions
- Ultrasonography, DopplerPeripheral Arterial Disease
- First Posted Date
- 2022-05-13
- Last Posted Date
- 2022-07-29
- Target Recruit Count
- 17
- Registration Number
- NCT05373875
- Locations
- 🇬🇧
University Hospitals Bristol and Weston NHS Foundation Trust, Bristol, United Kingdom
Newly Diagnosed Immune Thrombocytopenia Testing the Standard Steroid Treatment Against Combined Steroid & Mycophenolate
- Conditions
- Immune Thrombocytopenia
- Interventions
- First Posted Date
- 2017-05-17
- Last Posted Date
- 2022-10-26
- Target Recruit Count
- 123
- Registration Number
- NCT03156452
- Locations
- 🇬🇧
University Hospital Bristol NHS Foundation Trust, Bristol, United Kingdom
A Trial of Cabazitaxel Chemotherapy in Relapsed Locally Advanced &/or Metastatic Carcinoma of the Penis
- First Posted Date
- 2017-04-14
- Last Posted Date
- 2022-11-18
- Target Recruit Count
- 17
- Registration Number
- NCT03114254
- Locations
- 🇬🇧
Bristol Haematology and Oncology Centre, Horfield Road, Bristol, United Kingdom
🇬🇧Universitty College Hospitals NHS Trust, London, United Kingdom
Pilot Study of Cabazitaxel and Paclitaxel in HER2 Negative Breast Cancer
- Conditions
- HER2 Negative Metastatic Breast Cancer
- Interventions
- First Posted Date
- 2017-02-09
- Last Posted Date
- 2019-11-13
- Target Recruit Count
- 160
- Registration Number
- NCT03048942
- Locations
- 🇬🇧
Imperial Healthcare NHS Trust, London, Avon, United Kingdom
🇬🇧Royal United Hospital, Bath, United Kingdom
🇬🇧Blackpool Victoria Hospital, Blackpool, United Kingdom
- Prev
- 1
- 2
- 3
- 4
- 5
- Next
News
Cemiplimab Plus Chemotherapy Shows Promise in Advanced Penile Cancer EPIC Trial
Phase 2 EPIC trial demonstrates 62.1% clinical benefit rate at 12 weeks for cemiplimab combined with platinum-based chemotherapy in advanced penile carcinoma patients.